H.R. 5630: To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
This bill proposes amendments to the Public Health Service Act to enhance the information that states must include in their plans related to Substance Use Prevention, Treatment, and Recovery Services block grants. The key points of the bill can be summarized as follows:
Amendments to State Plan Requirements
The bill specifically targets the requirements under Section 1932(b)(1)(A) of the Public Health Service Act. It aims to add new obligations for states regarding their substance use treatment plans. The main changes propose that state plans must now include:
- Types of Drugs for Treatment: A description of the various types of drugs available for use in medication-assisted treatment within the state's care system.
- Medication-Assisted Treatment Programs: Information about the state’s programs or protocols designed to prevent drug diversion and misuse, as well as enforcement measures related to these programs.
- Data on Drug Misuse: Any data related to the misuse of drugs that are part of medication-assisted treatments. This includes instances where these treatments have been combined with other prescription drugs.
- Drug Screening Protocols: Data regarding the drug screening protocols in place within the state’s treatment system. This should specifically cover protocols for screening patients who are receiving medication-assisted treatment.
By including these additional requirements, the bill seeks to ensure that states provide comprehensive and specific information about their substance use treatment systems, which may help improve the effectiveness and monitoring of these programs.
Overall Goals
The overarching aim of this legislation is to enhance transparency and accountability in how states manage substance use treatment programs. By mandating detailed reporting on treatment methods and the effectiveness of these programs, the bill could help in addressing issues related to drug misuse and ensure that state-funded treatment services are used appropriately and effectively.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 30, 2025 | Introduced in House |
| Sep. 30, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.